Profusa, Inc.

Profusa, Inc. (Nasdaq: PFSA) is a San Francisco-based medical technology company focused on implantable biosensor platforms that enable continuous, tissue-integrated health monitoring, with applications spanning continuous glucose sensing and broader physiological surveillance. The company reached public markets through a SPAC combination and operates in the digital health and medical devices sector. Its August 31, 2026 Form 8-K filing, bearing accession number 0001213900-26-095405, reflects a current reporting obligation under its public-company status. Investors and analysts tracking PFSA's post-merger operating milestones and regulatory progress can access full filing history, shareholder structure, and deal analytics by signing up for a SpacDesk account at spacdesk.com.